UltraChoice 8

Company: Zoetis

Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Sordellii-Perfringens Types C & D Bacterin-Toxoid

For veterinary use only

This product has been shown to be effective for the vaccination of healthy cattle and sheep against disease caused by Clostridium chauvoei, Cl. septicum, Cl. haemolyticum, Cl. novyi, Cl. sordellii, and Cl. perfringens types C and D. Duration of immunity has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Although Cl. perfringens type B is not a significant problem in North America, immunity is provided by the beta toxoid of type C and the epsilon toxoid of type D.

Directions For Use

Mix well. Cattle: Aseptically administer 2 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered SC under the skin. Healthy cattle should receive 2 doses administered 4-6 weeks apart. Sheep: Aseptically administer 1 mL subcutaneously in the neck, followed by a second dose 4-6 weeks later. For more information on revaccination and in the face of Cl. haemolyticum exposure, contact your veterinarian.

Precautions

Store at 2°-8°C. Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Contains formalin as preservative. Temporary local swelling at injection site may occur after administration. Field reports indicate that a transient reduction in milk production may occur following vaccination. This product has not been tested in pregnant animals. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy. Do not mix with other products. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471.

VLN 190/PCN 7160.02

Zoetis Inc., Kalamazoo, MI 49007, USA

CPN: 3690077.3